SUPERFICIAL VEIN PROMINENCE

This adverse event was reported 258 times

These drugs are most commonly taken by patients reporting SUPERFICIAL VEIN PROMINENCE:

# Drug Count
0 INTERFERON BETA-1A 26
1 ASPIRIN 18
2 ASPIRIN 325 MG 17
3 ASPIRIN 81 MG 17
4 LEVOTHYROXINE SODIUM 17
5 IBUPFROFEN 16
6 IBUPROFEN 16
7 IBUPROFEN 200 MG 16
8 IBUPROFEN 200MG 16
9 IBUPROFEN CAPSULE 16
See all common drugs associated with SUPERFICIAL VEIN PROMINENCE

SUPERFICIAL VEIN PROMINENCE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRAZIQUANTEL 1 0.0033
1 PIMOZIDE 1 0.0021
2 NATEGLINIDE 2 0.0015
3 MECHLORETHAMINE HYDROCHLORIDE 2 0.0009
4 DANTROLENE SODIUM 1 0.0009
5 GADOTERATE MEGLUMINE 2 0.0005
6 HYDROCORTISONE SODIUM SUCCINATE 2 0.0005
7 SALINE NASAL SPRAY 2 0.0005
8 AVATROMBOPAG MALEATE 1 0.0004
9 CERITINIB 1 0.0004
See all drugs enriched for association with SUPERFICIAL VEIN PROMINENCE

SUPERFICIAL VEIN PROMINENCE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gadolinium-based Contrast Agent [EPC] 2 0.0004
1 Provitamin D2 Compound [EPC] 12 0.0004
2 Anthelmintic [EPC] 1 0.0003
3 Prostacyclin Receptor Agonist [EPC] 7 0.0003
4 Glinide [EPC] 2 0.0002
5 Ergot Derivative [EPC] 1 0.0002
6 Human Immunoglobulin G [EPC] 4 0.0002
7 Bismuth [EPC] 1 0.0002
8 Penem Antibacterial [EPC] 6 0.0002
9 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
See all drug classes enriched for association with SUPERFICIAL VEIN PROMINENCE